Singapore Firms Eye US Expansion Amid Trade and Regulatory Hurdles

Singaporean businesses are demonstrating a strong appetite for the United States market, with a significant delegation of around 30 companies participating in the SelectUSA Investment Summit. This marks the largest contingent from Singapore in recent years, underscoring the nation's strategic focus on expanding its economic footprint within the world's largest economy.

“

Singapore is definitely, in my view, a very attractive and strong place to go to access these breakthrough technologies that potentially could be brought to as a solution for the patient populations in the US.

The allure of the US market lies in its robust innovation ecosystem, ample access to capital, and the potential for valuable partnerships. Companies like Aevice Health, a medtech firm specializing in a smart wearable stethoscope for asthma patients, are actively seeking to scale their operations in the US. Their innovative technology has already garnered interest from major US healthcare institutions, highlighting the potential for cross-border technological collaboration.

However, the path to market entry is not without its hurdles. Singaporean firms are keenly aware of the ongoing trade tensions and regulatory uncertainties that characterize the US economic landscape. Navigating complex regulatory requirements and the unpredictable nature of tariffs poses significant challenges to long-term strategic planning and can directly impact profit margins, as noted by Aevice Health's co-founder and CEO, Adrian Ang.

“

What we do want to achieve next is to scale into more hospitals in the US, get our solutions out there, convert as many health systems as possible, so that we can actually bring these solutions to benefit asthma and COPD (chronic obstructive pulmonary disease) patients as much as possible in the near term.

Despite these challenges, the drive to expand into the US persists. The summit provides a crucial platform for these companies to engage with US investors and stakeholders, seeking to overcome market entry barriers. Singapore's own highly regarded innovation ecosystem is seen as a key enabler, fostering the development of breakthrough technologies that hold promise for addressing patient needs in the US. The success of these ventures will not only benefit the individual companies but also reinforce the strong economic ties between Singapore and the United States.

“

If you are the one that will pay for it, then that will eat into your bottomline.